Provention Bio, Inc.
Provention Bio, Inc., a clinical stage biopharmaceutical company, focuses on the development and commercialization of therapeutics and solutions to intercept and prevent immune-mediated diseases. Its products candidates include PRV-031 teplizumab and mon…
Biotechnology
US, Red Bank [HQ]
Revenue Breakdowns
Segment Analysis Beta
The financial segments are sourced from the SEC' 10-K statement.Revenue By Top Segments
Provention Bio, Inc. can't present it's sankey chart.
Historical Revenue By Segment
Last 3Y, in million USDProvention Bio, Inc. can't present revenue by segment
Get PRO Today
With PRO you can bypass the blur for the segment revenues of Provention Bio, Inc..
If you want to see a demo, head over to the financial segments of AAPL